Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis dose-blinded, randomized extension of the phase 2BOLDStudy

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • L. Kappos - (Author)
  • D.K.B. Li - (Author)
  • O. Stöve - (Author)
  • H.-P. Hartung - (Author)
  • M.S. Freedman - (Author)
  • B. Hemmer - (Author)
  • P. Rieckmann - (Author)
  • X. Montalban - (Author)
  • T. Ziemssen - , Department of Neurology (Author)
  • B. Hunter - (Author)
  • S. Arnould - (Author)
  • E. Wallström - (Author)
  • K. Selmaj - (Author)

Details

Original languageEnglish
JournalJAMA neurology
Publication statusPublished - 2016
Peer-reviewedYes

External IDs

Scopus 84999036775

Keywords